• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

Research Briefing on 3-(2-Methyl-4-(trifluoromethylthio)phenyl)propanenitrile (CAS: 1806451-64-8)

In recent years, the compound 3-(2-Methyl-4-(trifluoromethylthio)phenyl)propanenitrile (CAS: 1806451-64-8) has garnered significant attention in the field of chemical biology and pharmaceutical research. This nitrile derivative, characterized by its trifluoromethylthio moiety, has shown promising potential in various applications, including drug discovery and agrochemical development. The unique structural features of this compound, particularly the presence of the trifluoromethylthio group, contribute to its enhanced biological activity and metabolic stability, making it a valuable candidate for further investigation.

Recent studies have focused on the synthesis and optimization of 3-(2-Methyl-4-(trifluoromethylthio)phenyl)propanenitrile to improve its yield and purity. Advanced synthetic routes, such as palladium-catalyzed cross-coupling reactions and nucleophilic aromatic substitution, have been employed to achieve high efficiency and selectivity. These methodologies not only facilitate the scalable production of the compound but also enable the introduction of diverse functional groups, thereby expanding its applicability in medicinal chemistry.

The biological activity of 3-(2-Methyl-4-(trifluoromethylthio)phenyl)propanenitrile has been evaluated in several preclinical models. Preliminary findings suggest that this compound exhibits potent inhibitory effects on specific enzymatic targets, including kinases and proteases, which are implicated in various disease pathways. For instance, its interaction with the ATP-binding site of certain kinases has been demonstrated through X-ray crystallography and molecular docking studies, providing insights into its mechanism of action and potential therapeutic applications.

In addition to its pharmacological potential, 3-(2-Methyl-4-(trifluoromethylthio)phenyl)propanenitrile has also been explored for its utility in agrochemicals. The trifluoromethylthio group is known to enhance the lipophilicity and bioactivity of pesticidal compounds, making this derivative a promising candidate for the development of next-generation pesticides. Field trials have shown that derivatives of this compound exhibit improved efficacy against a broad spectrum of pests while maintaining favorable environmental safety profiles.

Despite these advancements, challenges remain in the development and commercialization of 3-(2-Methyl-4-(trifluoromethylthio)phenyl)propanenitrile. Issues such as metabolic stability, toxicity, and formulation optimization need to be addressed through further research. Collaborative efforts between academia and industry are essential to overcome these hurdles and unlock the full potential of this compound. Future studies should focus on structure-activity relationship (SAR) analyses to identify optimal derivatives and explore their applications in diverse therapeutic and agricultural contexts.

In conclusion, 3-(2-Methyl-4-(trifluoromethylthio)phenyl)propanenitrile (CAS: 1806451-64-8) represents a versatile and promising compound in the realms of drug discovery and agrochemical development. Its unique structural attributes and demonstrated biological activities underscore its potential as a lead candidate for further investigation. Continued research and innovation in this area are expected to yield significant contributions to the chemical biology and pharmaceutical industries.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)